Company intelligence / Profile preview

Natures Comfort Meds Biotechnology

Providence, Rhode Island, United States

Ownership: Private
Development stage: Other

Overview

NCM Biotech has developed a patented ethanol-based botanical extraction process yielding high CBD concentration, currently tested in pre-clinical/clinical studies for multiple indications including pain, autoimmune, and neurological diseases. Technology is licensed to partners, with positive anecdotal and preliminary results reported for several indications

Therapeutic areas: ImmunologyNeurologyPulmonologyPsychiatryOncology
Modalities: Small molecule (CBD/cannabinoid extracts)Biologic (hemp/cannabis botanical)
Industry: Biotech

Partnerships

Puration, Inc. (PURA)Greenbelt Resources Corporation (bioethanol supply for extraction)North American Cannabis Holdings

Beyond the preview

Go deeper on Natures Comfort Meds Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natures Comfort Meds Biotechnology.

Explore the full profile